Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac®

被引:17
作者
Trotter, Caroline L. [1 ]
Cibrelus, Laurence [2 ]
Fernandez, Katya [2 ]
Lingani, Clement [3 ]
Ronveaux, Olivier [2 ]
Stuart, James M. [4 ]
机构
[1] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England
[2] WHO, Dept Pandem & Epidem Dis, CH-1211 Geneva, Switzerland
[3] WHO, AFRO Intercty Support Team West Africa, Ouagadougou, Burkina Faso
[4] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England
关键词
Meningitis; Epidemic thresholds; Meningitis belt; Africa; MENINGOCOCCAL MENINGITIS; BACTERIAL-MENINGITIS; NEISSERIA-MENINGITIDIS; CONJUGATE VACCINE; SEQUELAE; OUTBREAK; CHILDREN; IMPACT; COSTS; NIGER;
D O I
10.1016/j.vaccine.2015.09.107
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Since 2010, countries in the African meningitis belt have been introducing a new serogroup A meningococcal conjugate vaccine (MenAfriVac (R)) through mass campaigns. With the subsequent decline in meningitis due to Neisseria meningitidis serogroup A (NmA) and relative increase in meningitis due to other serogroups, mainly N. meningitidis serogroup W (NmW), the World Health Organisation (WHO) initiated a review of the incidence thresholds that guide response to meningitis epidemics in the African meningitis belt. Methods: Meningitis surveillance data from African meningitis belt countries from 2002 to 2013 were used to construct a single NmW dataset. The performance of different weekly attack rates, used as thresholds to initiate vaccination response, on preventing further cases was estimated. The cumulative seasonal attack rate used to define an epidemic was also varied. Results: Considerable variation in effect at different thresholds was observed. In predicting epidemics defined as a seasonal cumulative incidence of 100/10(5) population, an epidemic threshold of 10 cases/10(5) population/week performed well. Based on this same epidemic threshold, with a 6 week interval between crossing the epidemic threshold and population protection from a meningococcal vaccination campaign, an estimated 17 cases per event would be prevented by vaccination. Lowering the threshold increased the number of cases per event potentially prevented, as did shortening the response interval. If the interval was shortened to 4 weeks at the threshold of 10/10(5), the number of cases prevented would increase to 54 per event. Conclusions: Accelerating time to vaccination could prevent more cases per event than lowering the threshold. Once the meningitis epidemic threshold is crossed, it is of critical importance that vaccination campaigns, where appropriate, are initiated rapidly. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6212 / 6217
页数:6
相关论文
共 28 条
[1]   The Economic Burden of Meningitis to Households in Kassena-Nankana District of Northern Ghana [J].
Akweongo, Patricia ;
Dalaba, Maxwell A. ;
Hayden, Mary H. ;
Awine, Timothy ;
Nyaaba, Gertrude N. ;
Anaseba, Dominic ;
Hodgson, Abraham ;
Forgor, Abdulai A. ;
Pandya, Rajul .
PLOS ONE, 2013, 8 (11)
[2]  
[Anonymous], 2011, Wkly Epidemiol Rec, V86, P521
[3]  
[Anonymous], 2014, Wkly Epidemiol Rec, V89, P206
[4]  
[Anonymous], 2000, Wkly Epidemiol Rec, V75, P306
[5]   Meningitis outbreak in Niger is an urgent warning [J].
Burki, Talha .
LANCET INFECTIOUS DISEASES, 2015, 15 (09) :1011-1011
[6]   Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012 [J].
Cibrelus, Laurence ;
Medah, Isaie ;
Koussoube, Daouda ;
Yelbeogo, Denis ;
Fernandez, Katya ;
Lingani, Clement ;
Djingarey, Mamoudou ;
Hugonnet, Stephane .
EMERGING INFECTIOUS DISEASES, 2015, 21 (11) :2063-2066
[7]   Costs and impact of meningitis epidemics for the public health system in Burkina Faso [J].
Colombini, Anais ;
Badolo, Ousmane ;
Gessner, Bradford D. ;
Jaillard, Philippe ;
Seini, Emmanuel ;
Da Silva, Alfred .
VACCINE, 2011, 29 (33) :5474-5480
[8]   Costs for Households and Community Perception of Meningitis Epidemics in Burkina Faso [J].
Colombini, Anais ;
Bationo, Fernand ;
Zongo, Sylvie ;
Ouattara, Fatoumata ;
Badolo, Ousmane ;
Jaillard, Philippe ;
Seini, Emmanuel ;
Gessner, Bradford D. ;
Da Silva, Alfred .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (10) :1520-1525
[9]   Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience [J].
Djingarey, Mamoudou H. ;
Barry, Rodrigue ;
Bonkoungou, Mete ;
Tiendrebeogo, Sylvestre ;
Sebgo, Rene ;
Kandolo, Denis ;
Lingani, Clement ;
Preziosi, Marie-Pierre ;
Zuber, Patrick L. F. ;
Perea, William ;
Hugonnet, Stephane ;
Tolve, Nora Dellepiane de Rey ;
Tevi-Benissan, Carole ;
Clark, Thomas A. ;
Mayer, Leonard W. ;
Novak, Ryan ;
Messonier, Nancy E. ;
Berlier, Monique ;
Toboe, Desire ;
Nshimirimana, Deo ;
Mihigo, Richard ;
Aguado, Teresa ;
Diomande, Fabien ;
Kristiansen, Paul A. ;
Caugant, Dominique A. ;
LaForce, F. Marc .
VACCINE, 2012, 30 :B40-B45
[10]   Prospective Cohort Study of Disabling Sequelae and Quality of Life in Children With Bacterial Meningitis in Urban Senegal [J].
Edmond, Karen ;
Dieye, Yakou ;
Griffiths, Ulla K. ;
Fleming, Jessica ;
Ba, Ousseynou ;
Diallo, Ndiouga ;
Mulholland, Kim .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (11) :1023-1029